Copper Deficiency as Wilson's Disease Overtreatment: A Systematic Review.
Tomasz LitwinAgnieszka AntosJan BembenekAdam PrzybyłkowskiIwona Kurkowska-JastrzębskaMarta SkowrońskaAnna CzlonkowskaPublished in: Diagnostics (Basel, Switzerland) (2023)
Awareness of CD and regular monitoring of copper metabolism is needed during WD treatment. Temporary cessation of anti-copper treatment usually reverses serum copper reductions as well as pancytopenia; however, some symptoms, especially neuropathy and myelopathy, may persist.